Ji‐Fu Wei
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- Immunology and Allergy top 2%
- Allergic Rhinitis and Sensitization
Papers in
-
- RNA modifications and cancer 22
- Ion channel regulation and function 9
- Genetics 26
- Venomous Animal Envenomation and Studies 21
- Co-authors
- Haiwei Yang (21 shared papers)Qiang Ding (25 shared papers)Hao Yu (3 shared papers)Jie Han (3 shared papers)Liang Shi (16 shared papers)Hongcheng Lu (2 shared papers)Wenbo Yuan (2 shared papers)Rui Zhou (2 shared papers)
- Journals
- Toxicon (8 papers)International Journal of Molecular Medicine (7 papers)Expert Opinion on Therapeutic Patents (7 papers)Journal of Experimental & Clinical Cancer Research (6 papers)Oncotarget (5 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Ji‐Fu Wei
141 papers receiving 4.1k citations
Ji‐Fu Wei's Hit Papers
Peers
Comparison fields: 5 of 128
- Cancer Research 997
- Immunology and Allergy 249
- Virology 173
- Molecular Biology 2.5k
- Genetics 472
Countries citing papers authored by Ji‐Fu Wei
This map shows the geographic impact of Ji‐Fu Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji‐Fu Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji‐Fu Wei more than expected).
Fields of papers citing papers by Ji‐Fu Wei
This network shows the impact of papers produced by Ji‐Fu Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji‐Fu Wei. The network helps show where Ji‐Fu Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Ji‐Fu Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 144 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner Hit paper breakdown → | 2019 | 554 |
| 2 | 2021 | 223 | |
| 3 | 2016 | 199 | |
| 4 | 2019 | 170 | |
| 5 | 2018 | 149 | |
| 6 | 2020 | 123 | |
| 7 | 2020 | 90 | |
| 8 | 2020 | 87 | |
| 9 | 2022 | 87 | |
| 10 | 2017 | 80 | |
| 11 | 2009 | 79 | |
| 12 | 2009 | 65 | |
| 13 | 2021 | 61 | |
| 14 | 2021 | 60 | |
| 15 | 2021 | 56 | |
| 16 | 2007 | 54 | |
| 17 | 2006 | 54 | |
| 18 | 2019 | 54 | |
| 19 | 2021 | 53 | |
| 20 | L-amino acid oxidase from Trimeresurus jerdonii snake venom: purification, characterization, platelet aggregation-inducing and antibacterial effects. | 2002 | 53 |
About Ji‐Fu Wei
Ji‐Fu Wei is a scholar working on Molecular Biology, Genetics, Immunology and Allergy, Immunology and Oncology, having authored 144 papers that have together received 4.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (22 papers), Venomous Animal Envenomation and Studies (21 papers), Allergic Rhinitis and Sensitization (21 papers), Food Allergy and Anaphylaxis Research (14 papers), Cancer-related molecular mechanisms research (9 papers), Ion channel regulation and function (9 papers), Mast cells and histamine (9 papers) and Healthcare and Venom Research (8 papers). The work is most often cited by research in Cancer Research (997 citations), Immunology and Allergy (249 citations), Virology (173 citations), Molecular Biology (2.5k citations) and Genetics (472 citations). Ji‐Fu Wei has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Haiwei Yang, Qiang Ding, Hao Yu, Jie Han, Liang Shi, Hongcheng Lu, Wenbo Yuan, Rui Zhou, Xiao Yang and Qiang Lü. Their work appears in journals such as Toxicon, International Journal of Molecular Medicine, Expert Opinion on Therapeutic Patents, Journal of Experimental & Clinical Cancer Research and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.